Zoetis Inc. Accounts Payable
Zoetis Inc. (ZTS) had Accounts Payable of $452.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $452.00M.
- 2026-03-31: Accounts Payable, Current $507.00M.
- 2025-12-31: Accounts Payable, Current $445.00M; Accounts Payable, Current as first filed $487.00M.
- 2025-09-30: Accounts Payable, Current $410.00M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $452.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $507.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $445.00M 10-Q · filed 2026-08-06 | $487.00M 10-K · filed 2026-02-12 |
| 2025-09-30 | $410.00M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $508.00M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $420.00M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $433.00M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $404.00M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $420.00M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $405.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $411.00M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $388.00M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $464.00M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $424.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $405.00M 10-K · filed 2024-02-13 | |
| 2022-09-30 | $373.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $430.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $402.00M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $436.00M 10-K · filed 2023-02-14 | |
| 2021-09-30 | $387.00M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $369.00M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $346.00M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $457.00M 10-K · filed 2022-02-15 | |
| 2020-09-30 | $357.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $335.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $265.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $301.00M 10-K · filed 2021-02-16 | |
| 2019-09-30 | $284.00M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $290.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $235.00M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $313.00M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $238.00M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $230.00M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $217.00M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $261.00M 10-K · filed 2019-02-14 | |
| 2017-10-01 | $213.00M 10-Q · filed 2017-11-02 | |
| 2017-07-02 | $199.00M 10-Q · filed 2017-08-08 | |
| 2017-04-02 | $231.00M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $265.00M 10-K · filed 2018-02-15 | |
| 2016-10-02 | $241.00M 10-Q · filed 2016-11-03 | |
| 2016-07-03 | $224.00M 10-Q · filed 2016-08-05 | |
| 2016-04-03 | $210.00M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $293.00M 10-K · filed 2017-02-16 | |
| 2015-09-27 | $306.00M 10-Q · filed 2015-11-05 | |
| 2015-06-28 | $278.00M 10-Q · filed 2015-08-06 | |
| 2015-03-29 | $256.00M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $290.00M 10-K · filed 2016-02-24 | |
| 2014-09-28 | $259.00M 10-Q · filed 2014-11-10 | |
| 2014-06-29 | $337.00M 10-Q · filed 2014-08-12 | |
| 2014-03-30 | $363.00M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $506.00M 10-K · filed 2015-02-27 | |
| 2013-09-29 | $482.00M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $587.00M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $275.00M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $319.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |